T

Bio-Techne Corp

TECH

82.360
USD
0.79
(0.97%)
Market Closed
Volume
15,709
EPS
0
Div Yield
0
P/E
67
Market Cap
11,103,598,265
Related Instruments
AAPL
-3.610
(-1.63%)
218.370 USD
AMZN
-3.000
(-1.60%)
183.990 USD
CRM
-5.730
(-2.21%)
253.060 USD
GOOGL
-0.710
(-0.41%)
170.760 USD
IBM
-2.600
(-1.35%)
189.660 USD
MSFT
-1.14
(-0.27%)
417.07 USD
NFLX
-3.53
(-0.56%)
624.46 USD
NVDA
-7.750
(-6.62%)
109.380 USD
TSLA
-15.150
(-6.53%)
216.890 USD
News

Title: Bio/Techne Corp

Sector: Healthcare
Industry: Biotechnology
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of theworld accounting for the remaining 5%.